Literature DB >> 15139497

Comparison of health-related quality of life preferences between physicians and cirrhotic patients: implications for cost-utility analyses in chronic liver disease.

C D Wells1, W B Murrill, M R Arguedas.   

Abstract

Accurate assessment of utilities to calculate quality-adjusted life expectancy for medical interventions is needed in cirrhosis. To date, limited data exist in cirrhotics and are generally physician-assigned. Therefore, our aim was to determine utilities for six clinical scenarios in cirrhosis and to define if differences exist in utilities assigned by physicians versus patients. We administered a questionnaire to 83 physicians and 114 cirrhotics to obtain utilities using the time trade-off method for (1) compensated cirrhosis, (2) decompensated cirrhosis, (3) encephalopathy, (4) spontaneous bacterial peritonitis, (5) variceal bleeding, and (5) hepatocellular carcinoma. On a scale from 0 (death) to 1 (perfect health), mean utilities of physicians and patients were compared using the Student t test. One-way analysis of variance was used to compare the utilities between patients according to Child-Pugh class. Statistical significance was defined as a P value <0.05. The mean age of the physicians was 42 +/- 11, with 52% being male. The mean age of the patients was 52 +/- 9; with 59% male. The mean Child-Pugh score was 8 +/- 2 and HCV was the most common etiology (54%). The mean utilities for physicians and patients were as follows: CC, 0.78 vs. 0.88; DC, 0.55 vs. 0.74; E, 0.38 vs. 0.55; SBP, 0.33 vs. 0.45; VB, 0.27 vs. 0.40; and HCC, 0.19 vs. 0.30. All comparisons were statistically significant. Although physicians and patients assigned similar relative rankings to each health state, physicians assigned utilities were significantly different from those assigned by patients. These results suggest that studies that have used physician-assigned utilities do not accurately reflect patient preferences.

Entities:  

Mesh:

Year:  2004        PMID: 15139497     DOI: 10.1023/b:ddas.0000020502.46886.c1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

1.  Strategies and pitfalls in quality of life research.

Authors:  R S Brown
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

Review 2.  Reduced quality of life in hepatitis C--is it all in the head?

Authors:  Daniel M Forton; Simon D Taylor-Robinson; Howard C Thomas
Journal:  J Hepatol       Date:  2002-03       Impact factor: 25.083

3.  A psychometric comparison of health-related quality of life measures in chronic liver disease.

Authors:  G Unal; J B de Boer; G J Borsboom; J T Brouwer; M Essink-Bot; R A de Man
Journal:  J Clin Epidemiol       Date:  2001-06       Impact factor: 6.437

4.  Development and evaluation of the Liver Disease Quality of Life instrument in persons with advanced, chronic liver disease--the LDQOL 1.0.

Authors:  I M Gralnek; R D Hays; A Kilbourne; H R Rosen; E B Keeffe; L Artinian; S Kim; D Lazarovici; D M Jensen; R W Busuttil; P Martin
Journal:  Am J Gastroenterol       Date:  2000-12       Impact factor: 10.864

5.  Assessment of utilities and health-related quality of life in patients with chronic liver disease.

Authors:  Z M Younossi; N Boparai; M McCormick; L L Price; G Guyatt
Journal:  Am J Gastroenterol       Date:  2001-02       Impact factor: 10.864

Review 6.  Quality of life in cirrhotics with minimal hepatic encephalopathy.

Authors:  H Schomerus; W Hamster
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

7.  Comorbidities and quality of life in patients with interferon-refractory chronic hepatitis C.

Authors:  R J Fontana; C A Moyer; S Sonnad; N Sneed-Pee; J Walsh; S Klein; S Webster
Journal:  Am J Gastroenterol       Date:  2001-01       Impact factor: 10.864

8.  Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C.

Authors:  K B Hussain; R J Fontana; C A Moyer; G L Su; N Sneed-Pee; A S Lok
Journal:  Am J Gastroenterol       Date:  2001-09       Impact factor: 10.864

9.  Health values of patients infected with human immunodeficiency virus. Relationship to mental health and physical functioning.

Authors:  J Tsevat; J G Solzan; K M Kuntz; J Ragland; J S Currier; R L Sell; M C Weinstein
Journal:  Med Care       Date:  1996-01       Impact factor: 2.983

Review 10.  Quality-of-life assessments and chronic liver disease.

Authors:  Z M Younossi; G Guyatt
Journal:  Am J Gastroenterol       Date:  1998-07       Impact factor: 10.864

View more
  19 in total

1.  Managing mesh exposure following vaginal prolapse repair: a decision analysis comparing conservative versus surgical treatment.

Authors:  Laura C Skoczylas; Jonathan P Shepherd; Kenneth J Smith; Jerry L Lowder
Journal:  Int Urogynecol J       Date:  2012-06-30       Impact factor: 2.894

Review 2.  Management of solitary 1 cm to 2 cm liver nodules in patients with compensated cirrhosis: a decision analysis.

Authors:  Karen E Bremner; Ahmed M Bayoumi; Morris Sherman; Murray D Krahn
Journal:  Can J Gastroenterol       Date:  2007-08       Impact factor: 3.522

3.  Retropubic and transobturator midurethral slings: a decision analysis to compare outcomes including efficacy and complications.

Authors:  Jonathan P Shepherd; Jerry L Lowder; Keisha A Jones; Kenneth J Smith
Journal:  Int Urogynecol J       Date:  2010-02-26       Impact factor: 2.894

4.  Is liver transplantation using organs donated after cardiac death cost-effective or does it decrease waitlist death by increasing recipient death?

Authors:  Leigh Anne Dageforde; Irene D Feurer; C Wright Pinson; Derek E Moore
Journal:  HPB (Oxford)       Date:  2012-07-04       Impact factor: 3.647

5.  Is antibiotic prophylaxis necessary before midurethral sling procedures for female stress incontinence? A decision analysis.

Authors:  Jonathan P Shepherd; Keisha A Jones; Oz Harmanli
Journal:  Int Urogynecol J       Date:  2013-08-01       Impact factor: 2.894

6.  Population-based utilities for upper extremity functions in the setting of tetraplegia.

Authors:  Ashwin N Ram; Catherine M Curtin; Kevin C Chung
Journal:  J Hand Surg Am       Date:  2009-11       Impact factor: 2.230

Review 7.  Patient-reported outcomes in vaccines research: relevance for decision-making.

Authors:  Desmond Curran; Eliazar Sabater Cabrera; Linda Nelsen
Journal:  Hum Vaccin Immunother       Date:  2021-02-19       Impact factor: 3.452

8.  Health-State Utilities in Liver Cirrhosis: A Cross-sectional Study.

Authors:  Peyman Adibi; Leila Akbari; Leila Sadat Kahangi; Fatemeh Abdi
Journal:  Int J Prev Med       Date:  2012-03

9.  Cost-effectiveness analysis of Tdap in the prevention of pertussis in the elderly.

Authors:  Lisa J McGarry; Girishanthy Krishnarajah; Gregory Hill; Michelle Skornicki; Narin Pruttivarasin; Cristina Masseria; Bhakti Arondekar; Stephen I Pelton; Milton C Weinstein
Journal:  PLoS One       Date:  2013-09-03       Impact factor: 3.240

10.  Ultrasound elastography for fibrosis surveillance is cost effective in patients with chronic hepatitis C virus in the UK.

Authors:  C Canavan; J Eisenburg; L Meng; K Corey; C Hur
Journal:  Dig Dis Sci       Date:  2013-05-30       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.